Pharmaceuticals News

PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies...

Cannara appoints Nicholas Fozard as Chief Financial Officer as Niko Sosiak transitions fully into his role as Chief Operating Officer.

MONTRÉAL, 01 sept. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») (TSX: LOVE) (OTCQX : LOVFF) (FRA : 8CB0), producteur verticalement intégré de cannabis...

Scribe Therapeutics to participate in upcoming investor conferences

MIRA reports positive 7-day toxicology results for non-opioid MIRA-55, supporting continued IND-enabling development for inflammatory pain.

In post hoc analysis of CARES-310 trial, combination improved mPFS versus sorafenib across age subgroupsCombination also improved mOS versus sorafenib in patients <50 years and ≥50 yearsElevar is...

SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics...

CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic...

SAN CLEMENTE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for...

CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth